Global Influenza Market is projected to reach $9.33 billion by 2021 Global Influenza Market is projected to reach $9.3 | 页面 4






North America Influenza Market
Europe Influenza Market
Asia-Pacific Influenza Market
Latin America Influenza Market
Middle-East & Africa Influenza Market
The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca
(United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline
(U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma
Corporation (Japan), CSL Limited (Australia).
The Influenza Market study offers the following deliverables:






Global, regional and country-level analysis and forecasts of the study market;
providing Insights on the geographical areas in which this industry is blooming
Segment-level analysis on basis of poduct type, application, colour along with
market size forecasts and y-o-y estimations to detect key areas of industry growth in
detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the
market and their impact on shifting market dynamics
Study of macro and micro environmental factors that effect the global market
presented in an extensive strategic analyses section containing PESTLE and Porter’s
Five Forces Analyses
A comprehensive listing of key market players along with company overview,
product portfolios, key financial information (subjected to availability), SWOT
analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations
in the field along with new product launches, comparative financial studies and
recent developments in the market by the major companies